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ABSTRACT 
The species Graptophylum pictum (L.) Griff, also known as “daun ungu” in Indonesia, is a 
traditional herbaceous plant believed to have antidiabetic potential. The number of people in the 
world with diabetes has increased dramatically over the recent years. The treatment of type II diabetes 
is complicated by several factors inherent to the disease. Elevated postprandial hyperglycemia is one 
of the risk factors and the intestinal digestive enzyme α-glucosidase plays a vital role in carbohydrate 
metabolism. One of the antidiabetic therapeutic approaches which reduces the postprandial 
glucose level in blood is by the inhibition of α-glucosidase. In this study, phytochemical analysis, α-
glucosidase inhibitory activity and enzyme kinetics of ethyl acetate- and hexane extracts of G. pictum 
were evaluated with the aim to analyze its antidiabetic potential. Phytochemical analysis revealed the 
presence of tannins, steroids, and alkaloids. Steroids were present in ethyl acetate extract but absent 
in hexane extract, while alkaloids were present in hexane extract but absent in ethyl acetate extract. 
The ethyl acetate and hexane extracts had 30.68 and 49.82% inhibitory effect on α-glucosidase 
activity respectively. The kinetics of glucosidase enzyme of ethyl acetate and hexane extracts were 
determined by Lineweaver Burk plots.  These exhibited uncompetitive and noncompetitive inhibition 
to alpha-glucosidase activity respectively. From the enzyme assay, we infer that ethyl acetate and 
hexane extracts of G. pictum contain potential α-glucosidase inhibitors that have the potential to be 
exploited for use in the treatment of diabetes
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1. INTRODUCTION 
Diabetes is a chronic metabolic disorder 
in which homeostasis of the carbohydrate, 
protein and lipid metabolism is improperly 
regulated by the pancreatic hormone, insulin; 
resulting in an increased blood glucose level 
i.e. hyperglycemia (Nagmoti & Juvekar 2013). 
Danaei et al. (2011) estimated a total of 347 
million people worldwide have diabetes. In 
2004, an estimated 3.4 million people died from 
consequences of high fasting blood sugar (WHO 
2009) and it is predicted that diabetes will be the 
7th leading cause of death in 2030 (WHO 2011). 
Glucose homeostasis is a key for the treatment of 
diabetes (Kaskoos 2013). The treatment of type 
II diabetes is complicated by several risk factors 
inherent to the disease (Kaskoos 2013). Elevated 
postprandial hyperglycemia is one of the risk 
factors (Gin & Rigalleau 2000). One important 
causes of postprandial hyperglycemia is the fast 
uptake of glucose in the intestine by the action 
of glucosidases, a class of enzymes that helps in 
the breakdown of complex carbohydrates (starch 
and oligosaccharides) into simple sugars such 
as maltose and glucose (Hua-Qiang et al. 2012; 
Gray 1995). Therefore one of the important 
therapeutic approaches to decrease postprandial 
hyperglycemia is to retard absorption of glucose 
through inhibition of carbohydrate hydrolyzing 
enzymes (α-glucosidase) (Nagmoti & Juvekar 
2013). Several α-glucosidase inhibitors, such as 
acarbose (Schmidt et al. 1977), miglitol (Pogano 
et al. 1995), and valiolamine (Horii et al. 1987) 
have been isolated and used in the management 
of diabetes mellitus. However, these drugs are 
associated with gastrointestinal side effects such 
as abdominal pain, flatulence and diarrhea in the 
patients, which might be caused by excessive 
inhibition of pancreatic α-amylase resulting 
in fermentation of undigested carbohydrates 
in the colon by the colonic flora (Bhat et al. 
2011; Suzuki et al. 2009). Thus searching for a 
new class of compounds is essential to address 
diabetes problems. The present work was 
undertaken to explore the antidiabetic potential 
of a plant G. pictum as a α-glucosidase enzyme 
inhibitor.
G. pictum, also known as “daun ungu” in 
Indonesia, is a medicinal plant from the family 
Acanthaceae distributed throughout Indonesia. 
The leaves have been used as traditional 
medicine for the treatment of  constipation, 
rheumatism, menstruation, hemorrhoids, 
urinary infections, scabies, swelling, maturing 
boils, smoothing skin, wounds, dermatitis, 
hepatomegaly, ear disease, laxative, and chancre 
(PT Eisai Indonesia editor, 1995). Studies on 
extracts from leaves of this plant have revealed 
analgesic, anti-inflamatory (Ozaki et al. 1989) 
and hypoglycemic (Olangbede-Dada et al. 2011) 
activities. Research has shown that aqueous 
and 70% ethanol extracts of G. pictum have 
inhibitory activity against this α-glucosidase 
with a percentage inhibition value of 40.03 and 
65.89% (Nurcholis et al. 2011).   This shows 
that extracts of G. pictum can be developed as an 
antidiabetic. Based on these results, this study 
investigates the phytochemical, antidiabetic 
activity in vitro and enzyme kinetics of ethyl 
acetate and hexane extracts of G. pictum.
2. MATERIALS AND METHODS
Preparation of ethyl acetate and hexane 
extracts  
Fresh leaves of G. pictum collected 
from The Conservation and Cultivation Unit 
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of Biopharmaca Research Center, Bogor 
Agricultural University, were washed with 
water, cut into small pieces and dried for 5 days 
under the sun (moisture: < 10%). They were 
then ground to powder form (size: 80 mesh). 
As much as 30 g of powdered leaves were 
macerated using 10 x 30 mL ethyl acetate and 
hexane in a tightly closed round bottomed flask 
at room temperature for a period of 24 h and 
filtered with Whatman filter paper (type 4). 
The whole process was repeated once and the 
filtrate was concentrated under reduced pressure 
on rotavapor (BUCHI, R-250, Switzerland) at 
50°C. The resulted concentrated extracts were 
used for the following experiments.
Phytochemical analysis 
The phytochemical composition of 
each extract was determined using standard 
phytochemical methods described by Harborne 
(1998).
α-Glucosidase inhibitory assay
The enzyme inhibitory activity toward 
α-glucosidase was evaluated according to the 
method previously reported by Shibano et al. 
(1997) with modification. The reaction mixture 
consisted of 50 μl of 0.1 M phosphate buffer (pH 
7.0), 25 μl of 0.5 mM PNPG (dissolved in 0.1 M 
phosphate buffer, pH 7.0), 10 μl of test sample 
(0.63%) /and or standard (acarbose) (1% w/v 
in DMSO) and 25 μl of α-glucosidase (Sigma-
Aldrich, USA) solution (a stock solution of 1 
mg/ml in 0.01 M phosphate buffer, pH 7.0, was 
diluted to 0.1 Unit/ml with the same buffer, pH 
7.0, immediately prior to the assay). This reaction 
mixture was then incubated at 37°C for 30 min. 
The reaction was then terminated by the addition 
of 100 μl of 0.2 M sodium carbonate solution. 
The enzymatic hydrolysis of the substrate was 
monitored based on the amount of p-nitrophenol 
released in the reaction mixture at 400 nm using 
a microplate reader.  Inhibition percentage was 
calculated using the equation: 
% Inhibition = [(C – S)/ C] x 100% 
with S = the absorbance of sample (S1-S0; 
with S1 = absorbance of samples with enzyme 
addition and S0 = absorbance of sample without 
enzyme addition) and C = absorbance of control 
solution (DMSO), without sample (blank).
Kinetics Analysis of α-glucosidase inhibiton
To determine the inhibitory activity of the 
ethyl acetate- and hexane extracts of G. pictum 
against α-glucosidase, increasing concentrations 
of PNPG (4-nitrophenyl α-D-glucopyranoside) 
was used as substrate in the absence and presence 
of plant extracts at different concentrations. 
The parameters of α-glucosidase inhibiton was 
determined by Lineweaver-Burk plot analysis 
of the data (Lineweaver & Burk 1934), which 
were calculated from the results according to the 
Michaelis Menten kinetics.
3. RESULTS
Extract of G. pictum leaves
The yield of the extraction process of G. 
pictum leaves using ethyl acetate and hexane 
was 0.85 g (2.8% w/w) and 0.59 g (2.0% w/w), 
respectively.
 
Phytochemical components of G. pictum 
leaves
The results obtained from the  phyto-
chemical screening conducted on the ethyl 
acetate- and hexane extracts of G. pictum are 
presented in Table 1. Flavonoids, saponins and 
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triterpenoids were absent in both the ethyl acetate 
and hexane extracts of G. pictum. The ethyl 
acetate extracts contain tannins and steroids, 
whereas the hexane extracts contain alkaloids 
and tannins.
α-Glucosidase inhibitory activity of G. pictum 
leaf extracts
The α-Glucosidase inhibition activity 
of the ethyl acetate- and hexane extracts and 
acarbose is shown in Fig 1.   The effective 
inhibition of α-glucosidase by ethyl acetate and 
hexane extracts of G. pictum were 30.68 and 
49.83%, respectively. Acarbose, used as the 
positive control, showed a percentage inhibition 
value of 77.58%, under similar assay conditions.
Kinetics of α-glucosidase inhibiton
The inhibition kinetics of ethyl acetate- and 
hexane extracts analyzed by Lineweaver-Burk 
plot analysis, indicated that it is an uncompetitive 
and noncompetitive inhibitor with respect to 
PNPG for α-glucosidase, respectively (Table 
2). The inhibitor concentration (%) was plotted 
on X-axis and 1/V (mM/min)-1 values obtained 
from the Lineweaver-Burk plot was plotted on 
the Y axis. The ethyl acetate extract of G. pictum 
behaved as an uncompetitive inhibitor (s) for 
α-glucosidase (Fig 2) and resulted in reduction 
of Vmax from 0.174 mM/ min-1 to 0.042 mM/ 
min-1 with a Km change from 0.080 to 0.0005 
mM. The kinetic studies showed that the hexane 
extract of G. pictum increased the maximum 
velocity of the enzyme activity (or Vmax) 
without much change in the Km values (Table 
2 & Fig 3). The kinetic results of hexane extract 
demonstrated that mechanism of α-glucosidase 
inhibition was reversible, and noncompetitive in 
nature. 
Table 1 Phytochemical constituents of ethyl acetate 











(+) = present and (-) = not detected
Figure 1 The inhibitory effect of ethyl acetate- and hexane extracts of G. pictum on α-glucosidase 
(positive control: acarbose (1%). The results are expressed as mean ± S.D., n=3.
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4. DISCUSSION
Diabetes mellitus is a common metabolic 
disorder which may eventually lead to multiple 
organ damage and syndromes (Rahimi et al. 
2005). There are an assorted number of plants 
and plant-derived-compounds have been used 
in the treatment of diabetes to control blood 
sugar, as the synthetic antidiabetic drugs have 
adverse side effects in humans (Nagmoti & 
Juvekar 2013). Glucosidase is the key enzyme 
involved in hydrolysis of carbohydrate and 
inhibitors of this enzyme may be exploited 
as therapeutic approaches for controlling 
postprandial hyperglycemia (Shim et al. 
2003; Bhat et al. 2011). Phytochemicals from 
plants such as phenolic compounds, saponins, 
flavonoids, glycosides, alkaloids etc. have been 
reported to play an important role in modulating 
glucosidase activity and can therefore contribute 
to the management of postpradial hyperglycemia 
(Pulok et al. 2006; Ani & Akhilender 2008). In 
the present study, experiments have been carried 
out to evaluate the phytochemical components 
and the potential of ethyl acetate- and hexane 
extracts of G. pictum in inhibiting α-glucosidase 
activity.
Here, we report the antidiabetic activity of 
ethyl acetate- and hexane extracts of G. pictum. 
The present finding of the phytochemical 
screening of the extracts confirmed the presence 
of several bioactive compounds such as alkaloids, 
tannins and steroids (Table 1) which could be 
responsible for the versatile medicinal properties 
of these plant extracts. This is in agreement with 
previous reports that phytochemicals from some 
plants are strong inhibitors of the α-glucosidase 
Table 2 Kinetic analysis of α-glucosidase by ethyl acetate- and hexane extracts of Graptophylum pictum
Extract 
concentration (%)
Ethyl acetate extract Hexane extract
Km (mM) Vmax (mM/ min-1) Km (mM) Vmax (mM/ min-1)
0 0.087 0.456 0.066 0.513
2 0.080 0.174 0.078 0.327
5 0.0005 0.042 0.071 0.492
Figure 2   Lineweaver-Burk plot of α-glucosidase and PNPG with (■) 2% and (▲) 5% of ethyl acetate 
extract of G. pictum.
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y = 82,33x + 24.001
y = 22.259x + 5.7423
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(Kwon et al. 2007). To determine the mode of 
inhibition toward α-glucosidase, the double 
reciprocal plot was constructed and it indicated 
a non-competitive inhibition of α-glucosidase 
by the hexane G. pictum extract (Table 2, Fig 
3). This suggests that the active components 
of the extract bind to sites other than the active 
site of the enzyme and combine with either 
free enzyme or enzyme substrate complex 
possibly interfering with the action of both 
(Mayur et al. 2010). The ethyl acetate extract 
of G. pictum (Table 2, Fig 2) has uncompetitive 
inhibitors of α-glucosidase. The commercial α-
glucosidase inhibitor, acarbose, is a competitive 
inhibitor of the enzyme and it is required at a 
higher concentration to reduce the post-prandial 
glucose level. The uncompetitive inhibitors bind 
to the enzyme-substrate complex, lowering the 
Km and the maximum enzyme activity (Vmax) 
(Gurudeeban et al. 2012).
In conclusion, in vitro studies clearly 
indicated that ethyl acetate- and hexane 
extracts of Grapthophylum pictum had 30.68 
and 49.82% inhibitory effect on α-glucosidase 
activity respectively. The inhibitory effect of 
ethyl acetate and hexane extracts of G. pictum 
on α-glucosidase may be linked to the presence 
of alkaloids, tannins and steroids which may be 
acting individually or in synergy.  The chemical 
compounds of the plant showed significant 
α-glucosidase inhibitory activity.  Further 
studies should be directed towards chemical 
isolation, purification and characterization, in 
order to elucidate the components responsible 
for inhibiting activity as these may have 
importance for the development of antidiabetic 
agents.
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Figure 3 Line weaver-Burk plot of α-glucosidase and PNPG with (■) 2% and (▲) 5% of hexane 
extract of G. pictum.
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